Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: effects on cognition

R: A Language and Environment for Statistical Computing

R Core Team (2000) · doi:10.32614/r.manuals · Cited by 355,706 · see citing works

“Mini-mental state”

Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282 · see citing works

Fitting Linear Mixed-Effects Models Using <b>lme4</b>

Bates, D., Mächler, M., Bolker, B., & Walker, S. (2015) · Journal of Statistical Software · doi:10.18637/jss.v067.i01 · Cited by 86,835 · see citing works

<b>lmerTest</b> Package: Tests in Linear Mixed Effects Models

Kuznetsova, A., Brockhoff, P. B., & Christensen, R. H. B. (2017) · Journal of Statistical Software · doi:10.18637/jss.v082.i13 · Cited by 24,346 · see citing works

[Japanese version of the Neuropsychiatric Inventory--a scoring system for neuropsychiatric disturbance in dementia patients].

Hirono, N., Mori, E., Ikejiri, Y., Imamura, T., Shimomura, T., Hashimoto, M., Yamashita, H., & Ikeda, M. (1997) · PubMed · Cited by 21,010 · see citing works

Special Care Units and Traditional Care in Dementia: Relationship with Behavior, Cognition, Functional Status and Quality of Life - A Review

Kok, J. S., Berg, I. J., & Scherder, E. J. A. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000353441 · Cited by 20,589 · see citing works

Older Adults' Reasons for Using Technology while Aging in Place

Peek, S. T. M., Luijkx, K. G., Rijnaard, M. D., Nieboer, M. E., van der Voort, C. S., Aarts, S., van Hoof, J., Vrijhoef, H. J., & Wouters, E. (2015) · Gerontology · doi:10.1159/000430949 · Cited by 19,803 · see citing works

Sensitivity and False Alarm Rate of a Fall Sensor in Long-Term Fall Detection in the Elderly

Kangas, M., Korpelainen, R., Vikman, I., Nyberg, L., & Jämsä, T. J. (2014) · Gerontology · doi:10.1159/000362720 · Cited by 19,003 · see citing works

Pragmatics of measuring recognition memory: Applications to dementia and amnesia.

Snodgrass, J. G., & Corwin, J. (1988) · Journal of Experimental Psychology General · doi:10.1037//0096-3445.117.1.34 · Cited by 3,093 · see citing works

Pragmatics of measuring recognition memory: Applications to dementia and amnesia.

Snodgrass, J. G., & Corwin, J. (1988) · Journal of Experimental Psychology General · doi:10.1037/0096-3445.117.1.34 · Cited by 2,527 · see citing works

Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: a randomized double-blind trial

Griffiths, R. R., Johnson, M. W., Carducci, M. A., Umbricht, A., Richards, W. A., Richards, B. D., Cosimano, M. P., & Klinedinst, M. A. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116675513 · Cited by 2,201 · see citing works

Psychedelics

Nichols, D. E. (2016) · Pharmacological Reviews · doi:10.1124/pr.115.011478 · Cited by 1,762 · see citing works

Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial.

Ross, S., Bossis, A., Guss, J., Agin-Liebes, G., Malone, T., Cohen, B., Mennenga, S. E., Belser, A., Kalliontzi, K., Babb, J., et al. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116675512 · Cited by 1,698 · see citing works

Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance

Griffiths, R. R., Richards, W. A., McCann, U., & Jesse, R. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0457-5 · Cited by 1,684 · see citing works

Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study

Carhart-Harris, R. L., Bolstridge, M., Rucker, J., Day, C. M. J., Erritzoe, D., Kaelen, M., Bloomfield, M., Rickard, J. A., Forbes, B., Feilding, A., et al. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(16)30065-7 · Cited by 1,540 · see citing works

The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs.

Carhart-Harris, R. L., Leech, R., Hellyer, P. J., Shanahan, M., Feilding, A., Tagliazucchi, E., Chialvo, D. R., & Nutt, D. (2014) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2014.00020 · Cited by 1,252 · see citing works

Human hallucinogen research: guidelines for safety

Johnson, M., Richards, W., & Griffiths, R. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881108093587 · Cited by 1,203 · see citing works

Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin

Carhart-Harris, R. L., Erritzoe, D., Williams, T., Stone, J. M., Reed, L. J., Colasanti, A., Tyacke, R. J., Leech, R., Malizia, A. L., Murphy, K., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1119598109 · Cited by 1,172 · see citing works

Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study

Bogenschutz, M. P., Forcehimes, A. A., Pommy, J. A., Wilcox, C. E., Barbosa, P., & Strassman, R. J. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881114565144 · Cited by 1,151 · see citing works

Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action

Vollenweider, F. X., Vollenweider-Scherpenhuyzen, M. F. I., Bäbler, A., Vogel, H., & Hell, D. (1998) · NeuroReport · doi:10.1097/00001756-199812010-00024 · Cited by 1,018 · see citing works

The speed-accuracy tradeoff: history, physiology, methodology, and behavior

Heitz, R. P. (2014) · Frontiers in Neuroscience · doi:10.3389/fnins.2014.00150 · Cited by 952 · see citing works

Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects

Griffiths, R. R., Johnson, M. W., Richards, W. A., Richards, B. D., McCann, U., & Jesse, R. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2358-5 · Cited by 932 · see citing works

Pilot study of the 5-HT _2A R agonist psilocybin in the treatment of tobacco addiction

Johnson, M. W., Garcia-Romeu, A., Cosimano, M. P., & Griffiths, R. R. (2014) · Journal of Psychopharmacology · doi:10.1177/0269881114548296 · Cited by 914 · see citing works

Neural correlates of the LSD experience revealed by multimodal neuroimaging

Carhart-Harris, R. L., Muthukumaraswamy, S., Roseman, L., Kaelen, M., Droog, W., Murphy, K., Tagliazucchi, E., Schenberg, E. E., Nest, T., Orban, C., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1518377113 · Cited by 859 · see citing works

The neurobiology of psychedelic drugs: implications for the treatment of mood disorders

Vollenweider, F. X., & Kometer, M. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2884 · Cited by 723 · see citing works

Long-term follow-up of psilocybin-facilitated smoking cessation

Johnson, M. W., Garcia-Romeu, A., & Griffiths, R. R. (2017) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952990.2016.1170135 · Cited by 696 · see citing works

A cognitive neuroscience based computerized battery for efficient measurement of individual differences: Standardization and initial construct validation

Gur, R., Richard, J., Hughett, P., Calkins, M., Macy, L., Bilker, W., Brensinger, C., & Gur, R. E. (2009) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2009.11.017 · Cited by 578 · see citing works

Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors

Griffiths, R. R., Johnson, M. W., Richards, W. A., Richards, B. D., Jesse, R., MacLean, K. A., Barrett, F. S., Cosimano, M. P., & Klinedinst, M. A. (2018) · Journal of Psychopharmacology · doi:10.1177/0269881117731279 · Cited by 520 · see citing works

The pharmacology of psilocybin

Passie, T., Seifert, J., Schneider, U., & Emrich, H. M. (2002) · Addiction Biology · doi:10.1080/1355621021000005937 · Cited by 465 · see citing works

Receiver operating characteristics (ROCs) in recognition memory: A review.

Yonelinas, A. P., & Parks, C. M. (2007) · Psychological Bulletin · doi:10.1037/0033-2909.133.5.800 · Cited by 434 · see citing works

Differential psychopathology and patterns of cerebral glucose utilisation produced by (S)- and (R)-ketamine in healthy volunteers using positron emission tomography (PET)

Vollenweider, F. X., Leenders, K. L., Øye, I., Hell, D., & Angst, J. (1997) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(96)00042-9 · Cited by 413 · see citing works

Acute Effects of Lysergic Acid Diethylamide in Healthy Subjects

Schmid, Y., Enzler, F., Gasser, P., Grouzmann, E., Preller, K. H., Vollenweider, F. X., Brenneisen, R., Müller, F., Borgwardt, S., & Liechti, M. E. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.11.015 · Cited by 409 · see citing works

Computerized Neurocognitive Scanning: I. Methodology and Validation in Healthy People

Gur, R. C. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00278-0 · Cited by 399 · see citing works

Serotonin and hallucinogens

Aghajanian, G. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00135-3 · Cited by 371 · see citing works

An automated version of the digit symbol substitution test (DSST)

McLeod, D. R., Griffiths, R. R., Bigelow, G. E., & Yingling, J. E. (1982) · Behavior Research Methods · doi:10.3758/bf03203313 · Cited by 365 · see citing works

Activation of Serotonin 2A Receptors Underlies the Psilocybin-Induced Effects on Oscillations, N170 Visual-Evoked Potentials, and Visual Hallucinations

Kometer, M., Schmidt, A., Jancke, L., & Vollenweider, F. X. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.3007-12.2013 · Cited by 355 · see citing works

Psychometric Properties of the Penn Computerized Neurocognitive Battery

Moore, T. M., Reise, S. P., Gur, R. E., Hakonarson, H., & Gur, R. C. (2015) · Neuropsychology · doi:10.1037/neu0000093 · Cited by 325 · see citing works

Glutamate and the Neural Basis of the Subjective Effects of Ketamine: A Pharmaco–Magnetic Resonance Imaging Study

Deakin, J. F. W., Lees, J., McKie, S., Hallak, J. E. C., Williams, S. R., & Dursun, S. M. (2008) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2007.37 · Cited by 311 · see citing works

Potential Therapeutic Effects of Psilocybin

Johnson, M. W., & Griffiths, R. R. (2017) · Neurotherapeutics · doi:10.1007/s13311-017-0542-y · Cited by 301 · see citing works

Psilocybin – Summary of knowledge and new perspectives

Tylš, F., Páleníček, T., & Horáček, J. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.12.006 · Cited by 276 · see citing works

Cognitive, dissociative and psychotogenic effects of ketamine in recreational users on the night of drug use and 3 days later

Curran, H. V., & Morgan, C. J. A. (2000) · Addiction · doi:10.1046/j.1360-0443.2000.9545759.x · Cited by 245 · see citing works

Psilocybin-Induced Deficits in Automatic and Controlled Inhibition are Attenuated by Ketanserin in Healthy Human Volunteers

Quednow, B. B., Kometer, M., Geyer, M. A., & Vollenweider, F. X. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.228 · Cited by 230 · see citing works

Dextromethorphan An Overview of Safety Issues

Bem, J. L., & Peck, R. (1992) · Drug Safety · doi:10.2165/00002018-199207030-00004 · Cited by 226 · see citing works

Pharmacokinetics of Escalating Doses of Oral Psilocybin in Healthy Adults

Brown, R. T., Nicholas, C. R., Cozzi, N. V., Gassman, M. C., Cooper, K. M., Muller, D., Thomas, C. D., Hetzel, S. J., Henriquez, K. M., Ribaudo, A. S., et al. (2017) · Clinical Pharmacokinetics · doi:10.1007/s40262-017-0540-6 · Cited by 188 · see citing works

Dynamic brain network reconfiguration as a potential schizophrenia genetic risk mechanism modulated by NMDA receptor function

Braun, U., Schäfer, A., Bassett, D. S., Rausch, F., Schweiger, J. I., Bilek, E., Erk, S., Romanczuk‐Seiferth, N., Grimm, O., Geiger, L. S., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1608819113 · Cited by 183 · see citing works

The Effects of the Preferential 5-HT2A Agonist Psilocybin on Prepulse Inhibition of Startle in Healthy Human Volunteers Depend on Interstimulus Interval

Vollenweider, F., Csomor, P., Knappe, B., Geyer, M., & Quednow, B. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301324 · Cited by 159 · see citing works

Mismatch negativity generation in the human 5HT2A agonist and NMDA antagonist model of psychosis

Heekeren, K., Daumann, J., Neukirch, A., Stock, C., Kawohl, W., Norra, C., Waberski, T. D., & Gouzoulis‐Mayfrank, E. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1129-4 · Cited by 152 · see citing works

Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: similarities and differences in subjective experiences

Carbonaro, T. M., Johnson, M. W., Hurwitz, E., & Griffiths, R. R. (2018) · Psychopharmacology · doi:10.1007/s00213-017-4769-4 · Cited by 133 · see citing works

LSD modulates music-induced imagery via changes in parahippocampal connectivity

Kaelen, M., Roseman, L., Kahan, J., Santos-Ribeiro, A., Orbán, C., Lorenz, R., Barrett, F. S., Bolstridge, M., Williams, T., Williams, L., et al. (2016) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2016.03.018 · Cited by 131 · see citing works

Pharmacokinetics of Dextromethorphan and Metabolites in Humans

Schadel, M., Wu, D., Otton, S. V., KALOW, W., & Sellers, E. M. (1995) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199508000-00005 · Cited by 125 · see citing works

Ketamine Disrupts Frontal and Hippocampal Contribution to Encoding and Retrieval of Episodic Memory: An fMRI Study

Honey, G. D., Honey, R. A. E., O'Loughlin, C., Sharar, S. R., Kumaran, D., John Suckling, A., Menon, D. K., Sleator, C., Bullmore, E. T., & Fletcher, P. C. (2004) · Cerebral Cortex · doi:10.1093/cercor/bhh176 · Cited by 117 · see citing works

The mixed serotonin receptor agonist psilocybin reduces threat-induced modulation of amygdala connectivity

Kraehenmann, R., Schmidt, A., Friston, K., Preller, K. H., Seifritz, E., & Vollenweider, F. X. (2016) · NeuroImage: Clinical · doi:10.1016/j.nicl.2015.08.009 · Cited by 104 · see citing works

Ketamine modulates hippocampal neurochemistry and functional connectivity: a combined magnetic resonance spectroscopy and resting-state fMRI study in healthy volunteers

Kraguljac, N. V., Frölich, M. A., Tran, S., White, D. M., Nichols, N., Barton-McArdle, A., Reid, M. A., Bolding, M., & Lahti, A. C. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.122 · Cited by 102 · see citing works

The 5-HT2A/1A Agonist Psilocybin Disrupts Modal Object Completion Associated with Visual Hallucinations

Kometer, M., Cahn, B. R., Andel, D., Carter, O. L., & Vollenweider, F. X. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.10.002 · Cited by 99 · see citing works

Relative Abuse Liability of GHB in Humans: A Comparison of Psychomotor, Subjective, and Cognitive Effects of Supratherapeutic Doses of Triazolam, Pentobarbital, and GHB

Carter, L. P., Richards, B. D., Mintzer, M. Z., & Griffiths, R. R. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301146 · Cited by 96 · see citing works

The ROC Toolbox: A toolbox for analyzing receiver-operating characteristics derived from confidence ratings

Koen, J., Barrett, F., Harlow, I., & Yonelinas, A. (2016) · Behavior Research Methods · doi:10.3758/s13428-016-0796-z · Cited by 94 · see citing works

High doses of dextromethorphan, an NMDA antagonist, produce effects similar to classic hallucinogens

Reissig, C. J., Carter, L. P., Johnson, M. W., Mintzer, M. Z., Klinedinst, M. A., & Griffiths, R. R. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2680-6 · Cited by 90 · see citing works

Serotonergic Hallucinogen-Induced Visual Perceptual Alterations.

Kometer, M., & Vollenweider, F. (2016) · Current topics in behavioral neurosciences · doi:10.1007/7854_2016_461 · Cited by 88 · see citing works

A processing approach to the working memory/long-term memory distinction: Evidence from the levels-of-processing span task.

Rose, N. S., & Craik, F. I. M. (2012) · Journal of Experimental Psychology Learning Memory and Cognition · doi:10.1037/a0026976 · Cited by 86 · see citing works

Psilocybin impairs high-level but not low-level motion perception

Carter, O. L., Pettigrew, J. D., Burr, D. C., Alais, D., Hasler, F., & Vollenweider, F. X. (2004) · Neuroreport · doi:10.1097/00001756-200408260-00023 · Cited by 84 · see citing works

Ketamine effects on brain function — Simultaneous fMRI/EEG during a visual oddball task

Musso, F., Brinkmeyer, J., Ecker, D., London, M. K., Thieme, G., Warbrick, T., Wittsack, H., Saleh, A., Greb, W., de Boer, P., et al. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2011.06.045 · Cited by 80 · see citing works

Effects of the hallucinogen psilocybin on habituation and prepulse inhibition of the startle reflex in humans

Gouzoulis‐Mayfrank, E., Heekeren, K., Thelen, B., Lindenblatt, H., Kovar, K. ‐., Sass, H., & Geyer, M. A. (1998) · Behavioural Pharmacology · doi:10.1097/00008877-199811000-00011 · Cited by 80 · see citing works

Ketamine induces a robust whole-brain connectivity pattern that can be differentially modulated by drugs of different mechanism and clinical profile

Joules, R., Doyle, O., Schwarz, A. J., O’Daly, O., Brammer, M. J., Williams, S., & Mehta, M. A. (2015) · Psychopharmacology · doi:10.1007/s00213-015-3951-9 · Cited by 76 · see citing works

Acute LSD effects on response inhibition neural networks

Schmidt, A., Müller, F., Lenz, C., Dolder, P. C., Schmid, Y., Zanchi, D., Lang, U. E., Liechti, M. E., & Borgwardt, S. (2017) · Psychological Medicine · doi:10.1017/s0033291717002914 · Cited by 63 · see citing works

Neuronal correlates of visual and auditory alertness in the DMT and ketamine model of psychosis

Daumann, J., Wagner, D. R., Heekeren, K., Neukirch, A., Thiel, C. M., & Gouzoulis‐Mayfrank, E. (2009) · Journal of Psychopharmacology · doi:10.1177/0269881109103227 · Cited by 62 · see citing works

LSD alters eyes‐closed functional connectivity within the early visual cortex in a retinotopic fashion

Roseman, L., Sereno, M. I., Leech, R., Kaelen, M., Orbán, C., McGonigle, J., Feilding, A., Nutt, D., & Carhart-Harris, R. L. (2016) · Human Brain Mapping · doi:10.1002/hbm.23224 · Cited by 59 · see citing works

Monitoring trends in dextromethorphan abuse using the National Poison Data System: 2000–2010

Wilson, M. D., Ferguson, R. W., Mazer-Amirshahi, M. E., & Litovitz, T. L. (2011) · Clinical Toxicology · doi:10.3109/15563650.2011.585429 · Cited by 57 · see citing works

Effects of ketamine on psychomotor, sensory and cognitive functions relevant for driving ability

Giorgetti, R., Marcotulli, D., Tagliabracci, A., & Schifano, F. (2015) · Forensic Science International · doi:10.1016/j.forsciint.2015.04.024 · Cited by 53 · see citing works

Pharmacological modulation of the neural basis underlying inhibition of return (IOR) in the human 5-HT2A agonist and NMDA antagonist model of psychosis

Daumann, J., Heekeren, K., Neukirch, A., Thiel, C. M., Möller‐Hartmann, W., & Gouzoulis‐Mayfrank, E. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1237-1 · Cited by 52 · see citing works

Prepulse inhibition of the startle reflex and its attentional modulation in the human S-ketamine and N,N-dimethyltryptamine (DMT) models of psychosis

Heekeren, K., Neukirch, A., Daumann, J., Stoll, M., Obradovic, M., Kovar, K. ‐., Geyer, M. A., & Gouzoulis‐Mayfrank, E. (2007) · Journal of Psychopharmacology · doi:10.1177/0269881107077734 · Cited by 50 · see citing works

Dextromethorphan

Banken, J. A., & Foster, H. R. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1432.003 · Cited by 50 · see citing works

Inhibition of Return in the Human 5HT2A Agonist and NMDA Antagonist Model of Psychosis

Gouzoulis‐Mayfrank, E., Heekeren, K., Neukirch, A., Stoll, M., Stock, C., Daumann, J., Obradovic, M., & Kovar, K. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300882 · Cited by 48 · see citing works

Neural correlates of S-ketamine induced psychosis during overt continuous verbal fluency

Nagels, A., Kirner-Veselinovic, A., Krach, S., & Kircher, T. T. J. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2010.08.021 · Cited by 35 · see citing works

Merging Clinical Neuropsychology and Functional Neuroimaging to Evaluate the Construct Validity and Neural Network Engagement of then-Back Task

Kearney-Ramos, T. E., Fausett, J. S., Gess, J. L., Reno, A. J., Peraza, J., Kilts, C., & James, G. A. (2014) · Journal of the International Neuropsychological Society · doi:10.1017/s135561771400054x · Cited by 29 · see citing works

Acute cognitive effects of high doses of dextromethorphan relative to triazolam in humans

Carter, L. P., Reissig, C. J., Johnson, M. W., Klinedinst, M. A., Griffiths, R. R., & Mintzer, M. Z. (2012) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2012.08.025 · Cited by 28 · see citing works

The Translation of Cognitive Paradigms for Patient Research

Luck, S. J., & Gold, J. M. (2007) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn036 · Cited by 27 · see citing works

Neuropsychological mechanisms of Digit Symbol Substitution Test impairment in Asperger Disorder

Yoran-Hegesh, R., Kertzman, S., Vishne, T., Weizman, A., & Kotler, M. (2009) · Psychiatry Research · doi:10.1016/j.psychres.2007.11.015 · Cited by 25 · see citing works

Alprazolam and DN-2327 (Pazinaclone) in humans: Psychomotor, memory, subjective, and reinforcing effects.

Mumford, G. K., Rush, C. R., & Griffiths, R. R. (1995) · Experimental and Clinical Psychopharmacology · doi:10.1037/1064-1297.3.1.39 · Cited by 18 · see citing works

Emotions and brain function are altered up to one month after a single high dose of psilocybin.

Barrett, F. S., Doss, M. K., Sepeda, N. D., Pekar, J. J., & Griffiths, R. R. (2020) · Scientific Reports · doi:10.1038/s41598-020-59282-y · Cited by 375 · see citing works

Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms

Inserra, A., De Gregorio, D., & Gobbi, G. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000056 · Cited by 232 · see citing works

Pharmacological, neural, and psychological mechanisms underlying psychedelics: A critical review

van Elk, M., & Yaden, D. B. (2022) · Neuroscience &amp; Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104793 · Cited by 221 · see citing works

Models of psychedelic drug action: modulation of cortical-subcortical circuits

Doss, M. K., Madden, M. B., Gaddis, A., Nebel, M. B., Griffiths, R. R., Mathur, B. N., & Barrett, F. S. (2021) · Brain · doi:10.1093/brain/awab406 · Cited by 198 · see citing works

Psilocybin acutely alters the functional connectivity of the claustrum with brain networks that support perception, memory, and attention

Barrett, F. S., Krimmel, S. R., Griffiths, R. R., Seminowicz, D. A., & Mathur, B. N. (2020) · NeuroImage · doi:10.1016/j.neuroimage.2020.116980 · Cited by 187 · see citing works

Receptor-informed network control theory links LSD and psilocybin to a flattening of the brain’s control energy landscape

Singleton, S. P., Luppi, A. I., Carhart-Harris, R. L., Cruzat, J., Roseman, L., Nutt, D., Deco, G., Kringelbach, M. L., Stamatakis, E. A., & Kuceyeski, A. F. (2022) · Nature Communications · doi:10.1038/s41467-022-33578-1 · Cited by 146 · see citing works

Spontaneous and deliberate creative cognition during and after psilocybin exposure

Mason, N. L., Kuypers, K. P. C., Reckweg, J. T., Müller, F., Tse, D. H. Y., Rios, B. D., Toennes, S. W., Stiers, P. L. J., Feilding, A., & Ramaekers, J. G. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01335-5 · Cited by 129 · see citing works

Optimal dosing for psilocybin pharmacotherapy: Considering weight-adjusted and fixed dosing approaches

Garcia-Romeu, A., Barrett, F. S., Carbonaro, T. M., Johnson, M. W., & Griffiths, R. R. (2021) · Journal of Psychopharmacology · doi:10.1177/0269881121991822 · Cited by 96 · see citing works

The acute effects of classic psychedelics on memory in humans

Healy, C. J. (2021) · Psychopharmacology · doi:10.1007/s00213-020-05756-w · Cited by 95 · see citing works

Depression, mindfulness, and psilocybin: possible complementary effects of mindfulness meditation and psilocybin in the treatment of depression. a review

Heuschkel, K., & Kuypers, K. P. C. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00224 · Cited by 86 · see citing works

The role of serotonin in declarative memory: A systematic review of animal and human research

Coray, R. C., & Quednow, B. B. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104729 · Cited by 81 · see citing works

Psychedelic therapy's transdiagnostic effects: A research domain criteria (RDoC) perspective

Kelly, J. R., Gillan, C. M., Prenderville, J., Kelly, C., Harkin, A., Clarke, G., & O'Keane, V. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.800072 · Cited by 69 · see citing works

Clinically relevant acute subjective effects of psychedelics beyond mystical experience

Yaden, D. B., Goldy, S. P., Weiss, B., & Griffiths, R. R. (2024) · Nature Reviews Psychology · doi:10.1038/s44159-024-00345-6 · Cited by 64 · see citing works

Hazy memories in the courtroom: A review of alcohol and other drug effects on false memory and suggestibility

Kloft, L., Monds, L. A., Blokland, A., Ramaekers, J. G., & Otgaar, H. (2021) · Neuroscience &amp; Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.02.012 · Cited by 56 · see citing works

Psychedelic drugs and perception: a narrative review of the first era of research

Aday, J. S., Wood, J. R., Bloesch, E. K., & Davoli, C. C. (2021) · Reviews in the Neurosciences · doi:10.1515/revneuro-2020-0094 · Cited by 52 · see citing works

Subjective features of the psilocybin experience that may account for its self-administration by humans: a double-blind comparison of psilocybin and dextromethorphan

Carbonaro, T. M., Johnson, M. W., & Griffiths, R. R. (2020) · Psychopharmacology · doi:10.1007/s00213-020-05533-9 · Cited by 49 · see citing works

Effect of lysergic acid diethylamide (LSD) on reinforcement learning in humans

Kanen, J. W., Luo, Q., Kandroodi, M. R., Cardinal, R. N., Robbins, T. W., Nutt, D. J., Carhart-Harris, R. L., & den Ouden, H. E. M. (2022) · Psychological Medicine · doi:10.1017/s0033291722002963 · Cited by 49 · see citing works

LSD, afterglow and hangover: Increased episodic memory and verbal fluency, decreased cognitive flexibility

Wießner, I., Olivieri, R., Falchi-Carvalho, M., Palhano-Fontes, F., Maia, L. O., Feilding, A., de Araújo, D. B., Ribeiro, S. T. G., & Tófoli, L. F. (2022) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2022.01.114 · Cited by 44 · see citing works

The costs and benefits of psychedelics on cognition and mood

Sayalı, C., & Barrett, F. S. (2023) · Neuron · doi:10.1016/j.neuron.2022.12.031 · Cited by 43 · see citing works

Assessment of the Acute Effects of 2C‐B vs. Psilocybin on Subjective Experience, Mood, and Cognition

Mallaroni, P., Mason, N. L., Reckweg, J. T., Paci, R., Ritscher, S., Toennes, S. W., Theunissen, E. L., Kuypers, K. P. C., & Ramaekers, J. G. (2023) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.2958 · Cited by 39 · see citing works

Psilocybin induces spatially constrained alterations in thalamic functional organizaton and connectivity

Gaddis, A., Lidstone, D. E., Nebel, M. B., Griffiths, R. R., Mostofsky, S. H., Mejia, A. F., & Barrett, F. S. (2022) · NeuroImage · doi:10.1016/j.neuroimage.2022.119434 · Cited by 37 · see citing works

Psilocybin’s effects on cognition and creativity: A scoping review

Bonnieux, J. N., VanderZwaag, B., Premji, Z., Garcia‐Romeu, A., & García-Barrera, M. A. (2023) · Journal of Psychopharmacology · doi:10.1177/02698811231179801 · Cited by 37 · see citing works

The Potential of Psychedelics for End of Life and Palliative Care

Yaden, D. B., Nayak, S. M., Gukasyan, N., Anderson, B. T., & Griffiths, R. R. (2021) · Current topics in behavioral neurosciences · doi:10.1007/7854_2021_278 · Cited by 33 · see citing works

Use of Psychedelics for Pain: A Scoping Review

Goel, A., Rai, Y., Sivadas, S., Diep, C., Clarke, H. A., Shanthanna, H., & Ladha, K. S. (2023) · Anesthesiology · doi:10.1097/aln.0000000000004673 · Cited by 32 · see citing works

Psychedelics as Novel Therapeutics in Alzheimer’s Disease: Rationale and Potential Mechanisms

Garcia‐Romeu, A., Darcy, S., Jackson, H., White, T., & Rosenberg, P. B. (2021) · Current topics in behavioral neurosciences · doi:10.1007/7854_2021_267 · Cited by 31 · see citing works

LSD and psilocybin flatten the brain’s energy landscape: insights from receptor-informed network control theoryPreprint

Singleton, S. P., Luppi, A. I., Carhart-Harris, R. L., Cruzat, J., Roseman, L., Nutt, D. J., Deco, G., Kringelbach, M. L., Stamatakis, E. A., & Kuceyeski, A. F. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.05.14.444193 · Cited by 30 · see citing works

Psychedelic-Assisted Therapy for People with Eating Disorders

Gukasyan, N., Schreyer, C. C., Griffiths, R. R., & Guarda, Á. S. (2022) · Current Psychiatry Reports · doi:10.1007/s11920-022-01394-5 · Cited by 31 · see citing works

Psychedelic Cognition—The Unreached Frontier of Psychedelic Science

Bălăeţ, M. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.832375 · Cited by 30 · see citing works

Unique effects of sedatives, dissociatives, psychedelics, stimulants, and cannabinoids on episodic memory: A review and reanalysis of acute drug effects on recollection, familiarity, and metamemory.

Doss, M. K., Samaha, J., Barrett, F. S., Griffiths, R. R., de Wit, H., Gallo, D. A., & Koen, J. D. (2023) · Psychological Review · doi:10.1037/rev0000455 · Cited by 33 · see citing works

Impact of psilocybin on cognitive function: A systematic review

Meshkat, S., Tello-Gerez, T. J., Gholaminezhad, F., Dunkley, B. T., Reichelt, A. C., Erritzøe, D., Vermetten, E. H. G. J. M., Zhang, Y., Greenshaw, A. J., Burback, L., et al. (2024) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.13741 · Cited by 29 · see citing works

Can psilocybin be safely administered under medical supervision? A systematic review of adverse event reporting in clinical trials

Roscoe, J., & Lozy, O. (2022) · Drug Science Policy and Law · doi:10.1177/20503245221085222 · Cited by 29 · see citing works

Virtual Reality as a Moderator of Psychedelic-Assisted Psychotherapy

Sekula, A. D., Downey, L. A., & Puspanathan, P. (2022) · Frontiers in Psychology · doi:10.3389/fpsyg.2022.813746 · Cited by 27 · see citing works

Classics in Chemical Neuroscience: Dextromethorphan (DXM)

McClure, E. W., & Daniels, R. N. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00088 · Cited by 26 · see citing works

Inter-individual variability in neural response to low doses of LSD

Hutten, N. R. P. W., Quaedflieg, C. W. E. M., Mason, N. L., Theunissen, E. L., Liechti, M. E., Duthaler, U., Kuypers, K. P. C., Bonnelle, V., Feilding, A., & Ramaekers, J. G. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-03013-8 · Cited by 21 · see citing works

The Health and Clinical Benefits of Medicinal Fungi

Hobbs, C. (2023) · Advances in biochemical engineering, biotechnology · doi:10.1007/10_2023_230 · Cited by 21 · see citing works

Psilocybin—Mediated Attenuation of Gamma Band Auditory Steady-State Responses (ASSR) Is Driven by the Intensity of Cognitive and Emotional Domains of Psychedelic Experience

Viktorin, V., Griškova-Bulanova, I., Voicikas, A., Dojčánová, D., Zach, P., Bravermanová, A., Andrashko, V., Tylš, F., Korčák, J., Viktorinová, M., et al. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12061004 · Cited by 20 · see citing works

Psychedelics action and schizophrenia

Maćkowiak, M. (2023) · Pharmacological Reports · doi:10.1007/s43440-023-00546-5 · Cited by 16 · see citing works

How Psychedelics Modulate Multiple Memory Mechanisms in Posttraumatic Stress Disorder

Doss, M. K., DeMarco, A., Dunsmoor, J. E., Cisler, J. M., Fonzo, G. A., & Nemeroff, C. B. (2024) · Drugs · doi:10.1007/s40265-024-02106-4 · Cited by 21 · see citing works

Pharmacologic Similarities and Differences Among Hallucinogens

Waters, K. (2021) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.1917 · Cited by 19 · see citing works

Prevalence study of drugs and new psychoactive substances in hair of ketamine consumers using a methanolic direct extraction prior to high-resolution mass spectrometry

Matey, J. M., Montalvo, G., García‐Ruiz, C., Zapata, F., López-Fernández, A., & Martínez, M. A. (2021) · Forensic Science International · doi:10.1016/j.forsciint.2021.111080 · Cited by 19 · see citing works

Cognitive functioning associated with acute and subacute effects of classic psychedelics and MDMA - a systematic review and meta-analysis

Basedow, L. A., Majić, T., Hafiz, N. J., Algharably, E. A. E., Kreutz, R. H., & Riemer, T. (2024) · Scientific Reports · doi:10.1038/s41598-024-65391-9 · Cited by 19 · see citing works

Human Cortical Serotonin 2A Receptor Occupancy by Psilocybin Measured Using [11C]MDL 100,907 Dynamic PET and a Resting-State fMRI-Based Brain Parcellation

Barrett, F. S., Zhou, Y., Carbonaro, T. M., Roberts, J., Smith, G. S., Griffiths, R. R., & Wong, D. F. (2022) · Frontiers in Neuroergonomics · doi:10.3389/fnrgo.2021.784576 · Cited by 18 · see citing works

Remembering Molly: Immediate and delayed false memory formation after acute MDMA exposure

Kloft, L., Otgaar, H., Blokland, A., Toennes, S. W., & Ramaekers, J. G. (2022) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2022.01.005 · Cited by 19 · see citing works

Cellular rules underlying psychedelic control of prefrontal pyramidal neuronsPreprint

Ekins, T. G., Brooks, I. A. W., Kailasa, S., Rybicki-Kler, C., Jedrasiak‐Cape, I., Donoho, E., Mashour, G. A., Rech, J. C., & Ahmed, O. J. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.10.20.563334 · Cited by 17 · see citing works

Neuropsychological Functioning in Users of Serotonergic Psychedelics – A Systematic Review and Meta-Analysis

Basedow, L. A., Riemer, T., Reiche, S., Kreutz, R. H., & Majić, T. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.739966 · Cited by 16 · see citing works

Awake or Sleeping? Maybe Both… A Review of Sleep-Related Dissociative States

Sodré, M. E. J., Wießner, I., Irfan, M., Schenck, C. H., & Mota-Rolim, S. A. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12123876 · Cited by 17 · see citing works

Psilocybin: From Psychiatric Pariah to Perceived Panacea

Fonzo, G. A., Wolfgang, A. S., Barksdale, B. R., Krystal, J. H., Carpenter, L. L., Kraguljac, N. V., Grzenda, A. L., McDonald, W. M., Widge, A. S., Rodríguez, C. I., et al. (2025) · American Journal of Psychiatry · doi:10.1176/appi.ajp.20230682 · Cited by 16 · see citing works

A Research Domain Criteria (RDoC)-Guided Dashboard to Review Psilocybin Target Domains: A Systematic Review

Pouyan, N., Khankahdani, Z. H., Sisi, F. Y., Lee, Y. L., Rosenblat, J. D., Teopiz, K. M., Lui, L. M. W., Subramaniapillai, M., Lin, K., Nasri, F., et al. (2022) · CNS Drugs · doi:10.1007/s40263-022-00944-y · Cited by 17 · see citing works

A Brief Review on the Potential of Psychedelics for Treating Alzheimer’s Disease and Related Depression

Pilozzi, A. R., Foster, S. L., Mischoulon, D., D, M. F. M., & Huang, X. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512513 · Cited by 15 · see citing works

Enhancing Agency in Posttraumatic Stress Disorder Therapies Through Sensorimotor Technologies

Adrien, V., Bosc, N., Peccia-Galletto, C., Diot, T., Claverie, D., Reggente, N., Trousselard, M., Bui, É., Baubet, T., & Schoeller, F. (2024) · Journal of Medical Internet Research · doi:10.2196/58390 · Cited by 15 · see citing works

Psilocybin: crystal structure solutions enable phase analysis of prior art and recently patented examples

Sherwood, A. M., Kargbo, R. B., Kaylo, K. W., Cozzi, N. V., Meisenheimer, P. L., & Kaduk, J. A. (2021) · Acta Crystallographica Section C Structural Chemistry · doi:10.1107/s2053229621013164 · Cited by 14 · see citing works

A Systematic Review of the Neurocognitive Effects of Psychedelics in Healthy Populations: Implications for Depressive Disorders and Post-Traumatic Stress Disorder

Velit-Salazar, M. R., Shiroma, P. R., & Cherian, E. (2024) · Brain Sciences · doi:10.3390/brainsci14030248 · Cited by 14 · see citing works

Co-administration of midazolam and psilocybin: differential effects on subjective quality versus memory of the psychedelic experience

Nicholas, C. R. N., Banks, M. I., Lennertz, R. C., Wenthur, C. J., Krause, B. M., Riedner, B. A., Smith, R., Hutson, P. R., Sauder, C. J., Dunne, J. D., et al. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-03059-8 · Cited by 13 · see citing works

How to Make Psychedelic-Assisted Therapy Safer

Villiger, D. (2024) · Cambridge Quarterly of Healthcare Ethics · doi:10.1017/s0963180124000604 · Cited by 13 · see citing works

Human behavioral pharmacology of psychedelics

Strickland, J. C., & Johnson, M. W. (2022) · Advances in pharmacology · doi:10.1016/bs.apha.2021.10.003 · Cited by 13 · see citing works

Psychedelic-Induced Serotonin 2A Receptor Downregulation Does Not Predict Swim Stress Coping in Mice

Pędzich, B. D., Medrano, M., Buckinx, A., Smolders, I. J., & Bundel, D. D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232315284 · Cited by 11 · see citing works

Double-Blind Comparison of the Two Hallucinogens Dextromethorphan and Psilocybin: Experience-Dependent and Enduring Psychological Effects in Healthy Volunteers

Mathai, D. S., Hilbert, S. N., Sepeda, N. D., Strickland, J. C., Griffiths, R. R., & Garcia‐Romeu, A. (2023) · Psychedelic Medicine · doi:10.1089/psymed.2023.0035 · Cited by 11 · see citing works

N-methyl-D-aspartate Receptors and Depression: Linking Psychopharmacology, Pathology and Physiology in a Unifying Hypothesis for the Epigenetic Code of Neural Plasticity

Comai, S., Martin, S. D., Mattarei, A., Guidetti, C., Pappagallo, M., Folli, F. B., Alimonti, A., & Manfredi, P. L. (2024) · Pharmaceuticals · doi:10.3390/ph17121618 · Cited by 12 · see citing works

LSD and language: Decreased structural connectivity, increased semantic similarity, changed vocabulary in healthy individuals

Wießner, I., Falchi-Carvalho, M., Daldegan‐Bueno, D., Palhano-Fontes, F., Olivieri, R., Feilding, A., de Araújo, D. B., Ribeiro, S. T. G., Mota, N. B., & Tófoli, L. F. (2023) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2022.12.013 · Cited by 9 · see citing works

Acute effects of psilocybin on attention and executive functioning in healthy volunteers: a systematic review and multilevel meta-analysis

Yousefi, P., Lietz, M. P., O'Higgins, F., Rippe, R. C. A., Hasler, G., van Elk, M., & Enriquez‐Geppert, S. (2025) · Psychopharmacology · doi:10.1007/s00213-024-06742-2 · Cited by 9 · see citing works

Psilocybin and 2C-B at Encoding Distort Episodic Familiarity

Doss, M. K., Mallaroni, P., Mason, N. L., & Ramaekers, J. G. (2024) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2024.06.008 · Cited by 8 · see citing works

Psilocybin intoxication did not affect daytime or sleep-related declarative memory consolidation in a small sample exploratory analysis

Nikolič, M., Viktorin, V., Zach, P., Tylš, F., Dudysová, D., Janků, K., Kopřivová, J., Kuchař, M., Brunovský, M., Horáček, J., et al. (2023) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2023.04.019 · Cited by 8 · see citing works

Psychedelika und Dissoziativa in der Psychiatrie: Herausforderungen in der Behandlung

Jungwirth, J., Bavato, F., & Quednow, B. B. (2024) · Der Nervenarzt · doi:10.1007/s00115-024-01727-0 · Cited by 7 · see citing works

Ayahuasca enhances the formation of hippocampal-dependent episodic memory without impacting false memory susceptibility in experienced ayahuasca users: An observational study

Doss, M. K., Kloft, L., Mason, N. L., Mallaroni, P., Reckweg, J. T., van Oorsouw, K. I. M., Tupper, N., Otgaar, H., & Ramaekers, J. G. (2024) · Journal of Psychopharmacology · doi:10.1177/02698811241301216 · Cited by 8 · see citing works

LIMITATIONS ON THE SCIENTIFIC STUDY OF DRUG‐ENABLED MYSTICAL EXPERIENCES

Jones, R. H. (2019) · Zygon® · doi:10.1111/zygo.12546 · Cited by 7 · see citing works

The effects of psilocybin on cognition and emotional processing in healthy adults and adults with depression: a systematic literature review

Ramos, L., & Vicente, S. (2024) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803395.2024.2363343 · Cited by 6 · see citing works

New Insights Into the Clinical and Nonclinical Effects of Psychedelic Substances

Forstmann, M., & Sagioglou, C. (2021) · European Psychologist · doi:10.1027/1016-9040/a000447 · Cited by 6 · see citing works

Effects of psychedelic, DOI, on nucleus accumbens dopamine signaling to predictable rewards and cues in rats

Martin, D. A., Delgado, A. M., & Calu, D. J. (2024) · Neuropsychopharmacology · doi:10.1038/s41386-024-01912-4 · Cited by 7 · see citing works

The Potential Role of Psilocybin in Traumatic Brain Injury Recovery: A Narrative Review

Palmer, C., Ferber, A. T., & Greenwald, B. D. (2025) · Brain Sciences · doi:10.3390/brainsci15060572 · Cited by 5 · see citing works

Learning how to make use of dissociative therapies

Mathai, D. S. (2024) · International Review of Psychiatry · doi:10.1080/09540261.2024.2406329 · Cited by 5 · see citing works

Teaching a new dog old tricks: bringing rigor, grounding, and specificity to psychedelic neuropsychopharmacology

Heller, N. H., & Barrett, F. S. (2024) · Neuropsychopharmacology · doi:10.1038/s41386-024-01954-8 · Cited by 4 · see citing works

Pharmacology of memory

Doss, M. K., & Das, R. (2024) · Elsevier eBooks · doi:10.1016/b978-0-12-820480-1.00194-7 · Cited by 4 · see citing works

Cognitive control as a transdiagnostic mechanism of action in psychedelic effects

Sayalı, C., Truesdale, A., Rosen, D. S., & Barrett, F. S. (2025) · Cognitive Affective & Behavioral Neuroscience · doi:10.3758/s13415-025-01362-5 · Cited by 3 · see citing works

The ethical use of therapeutic touch in psychedelic-assisted therapy: a qualitative study of researcher perspectives and experiences

McHerron, D., Barber, M., Ham, R., Liknaitzky, P., Carter, A., & Gardner, J. (2025) · Therapeutic Advances in Psychopharmacology · doi:10.1177/20451253251377191 · Cited by 3 · see citing works

A critical review of brain entropy as a biomarker of the psychedelic state

Moses, B., Doss, M. K., & Tagliazucchi, E. (2026) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2026.106720 · Cited by 3 · see citing works

Psychedelics do not always enhance cognitive flexibility: The potential role of time-varying effects on reward learning processes

Kosted, R., Doss, M. K., Donegan, J. J., Cisler, J. M., & Fonzo, G. A. (2026) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2026.106788 · Cited by 3 · see citing works

Psychedelic visuals in context

Swanson, L. R. (2024) · doi:10.1093/oso/9780192898371.003.0006 · Cited by 3 · see citing works

Visual Hallucinations in Serotonergic Psychedelics and Lewy Body Diseases

Heller, N. H., Barrett, F. S., Buchborn, T., Collerton, D., Dupuis, D., Halberstadt, A. L., Jardri, R., Noorani, T. N., Preller, K. H., Taylor, J., et al. (2025) · Schizophrenia Bulletin · doi:10.1093/schbul/sbaf068 · Cited by 3 · see citing works

Microdosing psychedelics has no impact on cognitive function in naturalistic settings

Dinkelacker, J., & Pop, I. (2023) · Journal of Psychology & Clinical Psychiatry · doi:10.15406/jpcpy.2023.14.00738 · Cited by 3 · see citing works

Psychedelics and cognitive function: A systematic review

Cardoso, C. G., & Viana, M. D. B. (2023) · Research Society and Development · doi:10.33448/rsd-v12i14.44436 · Cited by 2 · see citing works

Effects of LSD, DMT and psilocybin on cognitive and psychological functions: A systematic review of the literature

Kase, M., Kaup, K., & Aru, J. (2026) · Journal of Psychopharmacology · doi:10.1177/02698811251412012 · Cited by 2 · see citing works

Disorders due to Substance Use: Hallucinogens and MDMA-Related Substances

Nayak, S. M., & Johnson, M. W. (2023) · Springer eBooks · doi:10.1007/978-3-030-42825-9_94-1 · Cited by 2 · see citing works

Disorders due to Substance Use: Hallucinogens and MDMA-Related Substances

Nayak, S. M., & Johnson, M. W. (2024) · Springer eBooks · doi:10.1007/978-3-030-51366-5_94 · Cited by 2 · see citing works

Societal Trends and Opportunities in the Aftermath of the Nova Psychedelic Trance Rave, Through Lilla and Benjamin

Halperin, D., On, T. B., Tadmor, N., Simon, A. M., Cherniak, A. D., & Simon, G. (2025) · Future Humanities · doi:10.1002/fhu2.70009 · Cited by 2 · see citing works

Acute Effects and Long-Term Neuropsychological Consequences of Classic Psychedelics Use

Basedow, L. A., & Riemer, T. (2025) · Current topics in behavioral neurosciences · doi:10.1007/7854_2025_600 · Cited by 2 · see citing works

Resetting the hippocampal buffer: a neurocognitive account of psychedelic therapy for anxiety-related psychopathology

McGovern, H. T., Wellman, N., Hutchinson, B. T., Oestreich, L., Cooper, S., Fonzo, G. A., & Doss, M. K. (2026) · Psychopharmacology · doi:10.1007/s00213-026-07163-z · Cited by 2 · see citing works

LSD, Afterglow and Hangover: Increased Episodic Memory and Verbal Fluency, Decreased Cognitive Flexibility

Wießner, I., Olivieri, R., Falchi-Carvalho, M., Palhano-Fontes, F., Maia, L. O., Feilding, A., de Araújo, D. B., Ribeiro, S. T. G., & Tófoli, L. F. (2022) · doi:10.54985/peeref.2209p2741243 · Cited by 2 · see citing works

The psychedelic, DOI, increases dopamine release in nucleus accumbens to predictable rewards and reward cuesPreprint

Martin, D. A., Delgado, A., & Calu, D. J. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.03.29.587390 · Cited by 2 · see citing works

Effects of ayahuasca on neuropsychological performance and social cognition: A systematic review

de Paula, C. C., Vicentini, A. B., Guerra, L. T. L., Bouso, J. C., Hallak, J. E. C., & SANTOS, R. G. D. (2026) · Journal of Psychopharmacology · doi:10.1177/02698811261424212 · Cited by 1 · see citing works

A Randomised, Triple-Blind, Dose-Finding Study of the Impact of Psilocybin on Motor Function in Healthy ParticipantsPreprint

Bhagavan, C., Carter, O. L., Nielsen, G., Berlowitz, D. J., Issak, S., Braat, S., Zaloumis, S. G., Attard, Z., Oliver, G., Mayne, D., et al. (2025) · medRxiv · doi:10.64898/2025.12.22.25342874 · Cited by 1 · see citing works

Hazy memories

Kloft, L. (2021) · doi:10.26481/dis.20210623lk

Differences in personality, cognitive abilities, illicit drug use, and white matter structural integrity between hallucinogen users and matched controlsPreprint

Aharon-Almagor, A., & Barrett, F. S. (2022) · Research Square · doi:10.21203/rs.3.rs-1529935/v1

The good, the bad, and the intoxicated

Mason, N. L. (2021) · doi:10.26481/dis.20210608nm

New insights into the clinical and nonclinical effects of psychedelic substances: an integrative reviewPreprint

Forstmann, M., & Sagioglou, C. (2021) · doi:10.31234/osf.io/2489x

Self-reported effects of classic psychedelics on stutteringPreprint

Gold, N. D., Goldway, N., Gerlach, H., & Jackson, E. S. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.04.18.537312

Metanálises em Psicologia: Uma Introdução Conceitual e Prática

de Lima, M. F. R., & Buratto, L. G. (2023) · Psico-USF · doi:10.1590/1413-82712023280205

How Does Psilocybin Therapy Work? an Exploration of Experiential Avoidance as a Putative Mechanism of Change

Zeifman, R. J. (2024) · doi:10.32920/26052859.v1 · Cited by 1 · see citing works

Effects of Psychedelic Drug Use on Neurocognitive Function and Psychological and Social Quality of Life Domains: An International Online StudyPreprint

Stadler, F., Saelens, J., Henter, I. D., Rieser, N. M., Greenwald, M. S., Ballard, E. D., Preller, K. H., Zarate, C. A., & Kraus, C. (2025) · medRxiv · doi:10.1101/2025.08.27.25334164

Causal Inference in Studies with Functional Unmasking: Psychedelics and BeyondPreprint

Loewinger, G. C., Stensrud, M. J., Nayak, S. M., Yaden, D. B., & Levis, A. W. (2025) · medRxiv · doi:10.64898/2025.12.05.25341713

Effects of cannabis and psychedelic use on cognitive, psychomotor, and driving performance: A review of recent literature

Camarena-Michel, A., & Rague, J. M. (2026) · Current Opinion in Toxicology · doi:10.1016/j.cotox.2026.100574

Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: similarities and differences in subjective experiences

Carbonaro, T. M., Johnson, M. W., Hurwitz, E., & Griffiths, R. R. (2018) · Psychopharmacology · doi:10.1007/s00213-017-4769-4 · Cited by 133 · see citing works

Double-Blind Comparison of the Two Hallucinogens Dextromethorphan and Psilocybin: Experience-Dependent and Enduring Psychological Effects in Healthy Volunteers

Mathai, D. S., Hilbert, S. N., Sepeda, N. D., Strickland, J. C., Griffiths, R. R., & Garcia‐Romeu, A. (2023) · Psychedelic Medicine · doi:10.1089/psymed.2023.0035 · Cited by 11 · see citing works

Rosalind Franklin Society Proudly Announces the 2023 Award Recipient for Psychedelic Medicine

Garcia‐Romeu, A. (2024) · Psychedelic Medicine · doi:10.1089/psymed.2024.65789.rfs2023

No evidence for deleterious effects of psilocybin and MDMA on working memory or related neurophysiological activity in a non-clinical population: An uncontrolled exploratory study

Bailey, N. W., Webb, S. L., Fitzgibbon, B. M., Denning, N. C., Dowie, T.-I., Schweickle, M. M., Modak, A., Chan, G., Knight, J., Waldron, M., et al. (2026) · Journal of Psychopharmacology · doi:10.1177/02698811261464991

High doses of dextromethorphan, an NMDA antagonist, produce effects similar to classic hallucinogens

Reissig, C. J., Carter, L. P., Johnson, M. W., Mintzer, M. Z., Klinedinst, M. A., & Griffiths, R. R. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2680-6 · Cited by 90 · see citing works